Companies: 10,795·Total market cap: $144.5T
Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA.CNCNQHealthcare● Active
$0.15
+$0.01(+7.41%)
Market Cap$15788646
P/E Ratio—
52W High$0.195
52W Low$0.085
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Pharmala Biotech Holdings Inc.（MDMA.CN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MDMA.CN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.02mdma.cn eps ttm · mdma.cn earnings per shareEarnings history
PE Ratio (TTM)—mdma.cn pe ratio ttm · mdma.cn price to earningsPE Ratio deep dive
Revenue (TTM)889568.00mdma.cn revenue ttm · mdma.cn annual revenueFull revenue history
Dividend Yield不分红does mdma.cn pay dividends · mdma.cn dividend yieldDividend history
Shares Outstanding99.6Mmdma.cn shares outstanding · mdma.cn floatShares outstanding history
Next EarningsTBAmdma.cn earnings date · mdma.cn next earningsEarnings history

探索 Pharmala Biotech Holdings Inc. 数据

mdma.cn stock data · financials
市值$15.8Mmdma.cn market cap · mdma.cn valuation
分析师预测—
股息不分红does pharmala biotech holdings inc. pay dividends · mdma.cn dividend yield
营收$605498-41.51%pharmala biotech holdings inc. annual revenue · mdma.cn revenue
盈利EPS $-0.02-134.41%mdma.cn earnings · mdma.cn eps
市盈率—mdma.cn pe ratio · mdma.cn price to earnings

财务快照

完整财报
FY 2025Revenue$605498.00▼ 41.51% YoY
202320242025
pharmala biotech holdings inc. revenue · mdma.cn revenue 2025
FY 2025Net Income-$2.2M▼ 164.12% YoY
202320242025
pharmala biotech holdings inc. net income · mdma.cn profit 2025
FY 2025EPS$-0.02▼ 134.41% YoY
202320242025
mdma.cn eps · pharmala biotech holdings inc. earnings per share 2025
TTM:Revenue: $889568.00Net Income: -$1.6MEPS: $-0.02View income statement →

股票表现

完整历史
1D+7.41%
1W-6.45%
1M+0.00%
3M+31.82%
YTD+31.82%
1Y+38.10%
5Y+81.25%

关于 Pharmala Biotech Holdings Inc.

CEONicholas Kadysh
IPO DateJan 11, 2022
Employees—
CountryCA
Websitepharmala.ca

Pharmala Biotech Holdings Inc. doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ing…

BiotechnologyHealthcareCNQCA

what is pharmala biotech holdings inc. · mdma.cn stock overview · pharmala biotech holdings inc. company profile · who is pharmala biotech holdings inc. ceo · mdma.cn CNQ · pharmala biotech holdings inc. headquarters · pharmala biotech holdings inc. business segments

关于股票概览与关键数据

Pharmala Biotech Holdings Inc.（MDMA.CN）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 11, 2022 在 CNQ 上市。截至最近交易日，MDMA.CN 股价为 $0.14，市值约为 $15.8M。过去12个月累计回报 +38.10%，年初至今回报 +31.82%。

2025 财年 Pharmala Biotech Holdings Inc. 营收 $605498.00。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Pharmala Biotech Holdings Inc.（MDMA.CN）股价为 $0.14，在 CNQ 上市，52周区间为 $0.09 – $0.20。

MDMA.CN 最新股价MDMA.CN quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议